Terms: = Leukemia AND EWSR1, EWS, 2130, ENSG00000182944
168 results:
1. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Baumgartner F; Baer C; Bamopoulos S; Ayoub E; Truger M; Meggendorfer M; Lenk M; Hoermann G; Hutter S; Müller H; Walter W; Müller ML; Nadarajah N; Blombery P; Keller U; Kern W; Haferlach C; Haferlach T
Blood; 2024 Mar; 143(12):1139-1156. PubMed ID: 38064663
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of mRNA Expression of CD244 and Its Adapter Molecules in CD8+ T Cells in Acute leukemia.
Mohammadi M; Asgarian-Omran H; Najafi A; Valadan R; Karami H; Naderisoraki M; Zaboli E; Eslami M; Tehrani M
Iran Biomed J; 2023 Jul; 27(4):214-8. PubMed ID: 37634081
[TBL] [Abstract] [Full Text] [Related]
3. Neurologic Complications in Patients With Lymphoreticular Malignancy: A Descriptive Cohort Study.
Baloda R; Sharma S; Anand R; Mandal P; Parakh N; Katti B; Singh V; Chandra J
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e885-e891. PubMed ID: 37526372
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
[TBL] [Abstract] [Full Text] [Related]
5. ZNF384-Related Fusion Genes in Acute Lymphoblastic leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
6. CD43-positive, ewsr1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic leukemia.
Ohlsen TJD; Rudzinski ER; Bohling SD; Liu YJ; Maloney EJ; Lindberg AW; Albert CM; Lamble AJ; Taylor MR
J Pediatr Hematol Oncol; 2023 Jul; 45(5):e635-e638. PubMed ID: 37027334
[TBL] [Abstract] [Full Text] [Related]
7. Primary Intracranial Ewing Sarcoma Invading the Superior Sagittal Sinus with ewsr1-FLI1 Gene Fusion and ewsr1 Gene Mutation: A Case Report and Literature Review.
Geng Z; Gao W; Cheng W; Wu A
World Neurosurg; 2023 Jul; 175():1-10. PubMed ID: 36990350
[TBL] [Abstract] [Full Text] [Related]
8. Cutaneous syncytial myoepithelioma with folliculocentric growth and ewsr1 gene rearrangement: A case report.
Nagayasu MA; Tanaka H; Nogami K; Kukita Y; Nakamura H; Motoi T; Manabe T; Kataoka H
J Cutan Pathol; 2023 May; 50(5):400-404. PubMed ID: 36820993
[TBL] [Abstract] [Full Text] [Related]
9. Equivocal end-of-therapy imaging findings do not predict a higher risk of local relapse after definitive radiotherapy in pediatric Ewing sarcoma and rhabdomyosarcoma.
McLean-Thomas L; Gao D; Trenbeath Z; Cost CR; Milgrom SA
Pediatr Blood Cancer; 2023 May; 70(5):e29989. PubMed ID: 36726177
[TBL] [Abstract] [Full Text] [Related]
10. Exploration of Flavonoids as Lead Compounds against Ewing Sarcoma through Molecular Docking, Pharmacogenomics Analysis, and Molecular Dynamics Simulations.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Hassan M; Kloczkowski A; Chun W
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615603
[TBL] [Abstract] [Full Text] [Related]
11. Systemic inflammation caused by an intracranial mesenchymal tumor with a ewsr1::CREM fusion presenting associated with IL-6/STAT3 signaling.
Hojo K; Furuta T; Komaki S; Yoshikane Y; Kikuchi J; Nakamura H; Ide M; Shima S; Hiyoshi Y; Araki J; Tanaka S; Ozono S; Yoshida A; Nobusawa S; Morioka M; Nishikomori R
Neuropathology; 2023 Jun; 43(3):244-251. PubMed ID: 36328767
[TBL] [Abstract] [Full Text] [Related]
12. Nuclear Proteomics of Induced leukemia Cell Differentiation.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Archakov A; Zgoda V
Cells; 2022 Oct; 11(20):. PubMed ID: 36291090
[TBL] [Abstract] [Full Text] [Related]
13. Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response.
Cristalli C; Manara MC; Valente S; Pellegrini E; Bavelloni A; De Feo A; Blalock W; Di Bello E; Piñeyro D; Merkel A; Esteller M; Tirado OM; Mai A; Scotlandi K
Front Endocrinol (Lausanne); 2022; 13():876602. PubMed ID: 35712255
[TBL] [Abstract] [Full Text] [Related]
14. Inhibitors of EYA3 Protein in Ewing Sarcoma.
Shah FH; Kim SJ
Asian Pac J Cancer Prev; 2022 May; 23(5):1539-1545. PubMed ID: 35633536
[TBL] [Abstract] [Full Text] [Related]
15. Identification of ewsr1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature.
Gagnon MF; Smadbeck JB; Vasmatzis G; Olteanu H; Wood AJ; Lewis DJ; Sharma N; Meyer RG; Greipp PT; Xu X; Hoppman NL; Baughn LB; Ketterling RP; Chiu A; Peterson JF
Ann Diagn Pathol; 2022 Jun; 58():151942. PubMed ID: 35344861
[TBL] [Abstract] [Full Text] [Related]
16. FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.
Lindén M; Vannas C; Österlund T; Andersson L; Osman A; Escobar M; Fagman H; Ståhlberg A; Åman P
Mol Oncol; 2022 Jul; 16(13):2470-2495. PubMed ID: 35182012
[TBL] [Abstract] [Full Text] [Related]
17. Peripheral-type primitive neuroectodermal tumor of the ovary with ewsr1-FLI1 fusion transcript: a case report and brief review of literature.
Grigoriu C; Terzea DC; Lisievici AC; Georgescu TA; Constantin AE; Bacalbaşa N; Ducu I; Bohîlţea RE
Rom J Morphol Embryol; 2021; 62(2):581-586. PubMed ID: 35024748
[TBL] [Abstract] [Full Text] [Related]
18. The
Johnson CN; Xu X; Holloway SP; Libich DS
Biomol NMR Assign; 2022 Apr; 16(1):67-73. PubMed ID: 34994941
[TBL] [Abstract] [Full Text] [Related]
19. Cancer risk in individuals with intellectual disability in Sweden: A population-based cohort study.
Liu Q; Adami HO; Reichenberg A; Kolevzon A; Fang F; Sandin S
PLoS Med; 2021 Oct; 18(10):e1003840. PubMed ID: 34673770
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of ewsr1 (Ewing sarcoma breakpoint region 1/ews RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract] [Full Text] [Related]
[Next]
